Precision Medicine Integration Boosts Psychedelic Drugs Market Development The psychedelic drugs industry has been gaining significant momentum due to increasing interest in mental health therapies and novel treatment modalities. Recent advancements and clinical validations have elevated this sector, making the market an important focus for investors and healthcare innovators alike. Market Size and Overview The Global Psychedelic Drugs Market is estimated to be valued at USD 3.88 Bn in 2025 and is expected to reach USD 9.60 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 13.8% from 2025 to 2032. Psychedelic Drugs Market Forecast driven by rising clinical research, expanding regulatory acceptance, and growing demand for alternative therapies. Market trends reflect increasing involvement of pharmaceutical companies and research institutions, promoting positive market dynamics and reinforcing the market scope across various segments including depression, PTSD, and anxiety treatment. Psychedelic Drugs Market - https://www.coherentmarketinsights.com/industry-reports/psychedelic-drugs-market #PsychedelicDrugs #TherapeuticApplications #ClinicalResearch #MentalHealthTreatment #PsilocybinTherapy #CoherentMarketInsights